Core Viewpoint - Suncor Energy has announced a new 3-year improvement plan, increasing its annual share repurchases by over 20% to a revised projection of $4 billion for 2026 [1]. Group 1: Investor Day Highlights - The Investor Day presentation is available for live webcast and future viewing on Suncor's website [2]. - Suncor has filed a report disclosing its contingent resources, accessible on various platforms including SEDAR and SEC [2]. Group 2: Company Overview - Suncor Energy is recognized as Canada's leading integrated energy company, with operations covering the entire energy value chain, including oil sands mining, upgrading, offshore production, and petroleum refining [3]. - The company emphasizes safety, operational excellence, and profitability, aiming to deliver industry-leading performance and long-term shareholder value [3]. Group 3: Financial Projections and Goals - Suncor projects a $2 billion increase in normalized free funds flow by 2028 [8]. - The company aims for a US$5 per barrel reduction in corporate WTI breakeven to US$38 per barrel by 2028 [8]. - An increase of 100,000 barrels per day in upstream production is targeted by 2028 [8]. - Suncor plans a 10% increase in refining network nameplate capacity to 511,000 barrels per day [8]. - The company anticipates an 11 billion barrel increase in contingent resources, totaling 30 billion barrels with no exploration risk [8]. - Future production capacity is projected at 400,000 barrels per day, with an average cost of $30,000 per flowing barrel [8].

Core Viewpoint - Datavault AI and Coppercore Inc. have announced the tokenization of high-grade copper resources into Coppercoin™, aiming to set a new industry standard in tokenized copper with an initial issuance of $100 million [2][3]. Group 1: Tokenization Details - The transaction allows Datavault AI to utilize its patented blockchain tokenization platform to create Coppercoin™ digital tokens, representing pro-rata ownership interests in the underlying copper resources [3]. - Each Coppercoin™ token corresponds to five pounds of high-grade copper, with pricing linked to the COMEX copper benchmark [4]. - The initial program aims to mint $100 million or more in Digital Copper Tokens, scheduled for launch by the end of Q2 2026 [5]. Group 2: Market Dynamics - Coppercoin™ introduces a new digital asset class that enhances market efficiencies and opportunities, including the production of copper industrial products [6]. - Global copper demand is projected to increase by 24% by 2035 and up to 50% by 2040, driven by factors such as AI data centers and electrification [7]. - Traditional copper markets are complex and less accessible, but Coppercoin™ offers a transparent, fractional, and liquid digital ownership model, allowing global investors to participate in the copper market [8]. Group 3: Strategic Importance - The partnership between Datavault AI and Coppercore is a significant milestone in the tokenization of real-world assets, providing institutional-grade, verifiable, and liquid digital ownership [9]. - The tokenized assets will leverage Datavault AI's smart-contract technology for verifiable ownership and future revenue participation rights tied to copper production [9]. - This initiative supports the critical minerals supply chain essential for AI, electrification, and the energy transition [9].

Core Insights - Diginex is undergoing a strategic shift to transform from a collection of businesses into a unified platform aimed at serving the evolving compliance market [3][10] - The company aims to address market inefficiencies by integrating its capabilities across various compliance-related services, thereby reducing fragmentation and enhancing client engagement [5][6] Market Context - The compliance landscape has evolved rapidly but inefficiently, leading to a fragmented ecosystem that complicates data management for enterprise clients [4] - Increasing regulatory complexity and the rise of artificial intelligence are driving demand for integrated solutions over fragmented vendor offerings [8] Strategic Repositioning - Diginex is consolidating four operating entities into a single framework to streamline operations and align with client consumption patterns [5][6] - The integration will enhance the company's ability to engage with high-level decision-makers, such as CFOs and risk committees, by offering comprehensive solutions [6][7] Data Integration - The company processes hundreds of millions of sustainability-related data points monthly, and unifying these data flows will create a more robust compliance infrastructure [7] - This shift positions Diginex closer to decision-making processes within enterprises, enhancing its role in the financial and operational ecosystem [7] Commercial Implications - Early signs indicate increased client interest in bundled offerings that address multiple compliance needs, suggesting a shift in how solutions are perceived and engaged with [9] - The transition to a unified platform model is expected to deepen client relationships and expand the scope of engagements [9] Execution Focus - Diginex is now focused on executing its integration strategy, aligning product and technology roadmaps, and rebranding efforts to translate its vision into measurable outcomes [12] - The company is positioning itself to capture the value of its existing assets while operating cohesively in a market that increasingly rewards integration [10][13] Long-term Ambition - Diginex aims to establish itself as a global benchmark for institutional integrity, emphasizing the importance of data credibility and operational transparency [11] - The strategic reset positions Diginex to operate at the core of a more integrated market, aligning with the growing demand for reliable and scalable compliance solutions [13]

Financial Performance - Phreesia reported fourth-quarter earnings of 2 cents, missing the consensus estimate of 7 cents [1] - Sales reached $127.07 million, up 16% year-over-year, beating the consensus of $126.62 million [1] - The average number of healthcare service clients (AHSCs) was 4,658 in the quarter, reflecting a 7% year-over-year increase [1] Fiscal Guidance - The company lowered its fiscal 2027 revenue outlook to $510–$520 million, down from a previous range of $545–$559 million, due to reduced visibility into pharma client spending and weaker-than-expected commitments for the second half of the year [2] Key Milestones - CEO Chaim Indig highlighted several financial milestones, including achieving positive GAAP net income of $2.3 million, crossing $100 million in Adjusted EBITDA, and generating $50 million in free cash flow for fiscal year 2026 [3] - Phreesia shares experienced a significant decline of 28.6%, dropping to $8.14 in pre-market trading following the earnings announcement [3]

Group 1: Fund Performance - Platinum International Technology Fund achieved a 3% increase in Q4 2025 and a 13.1% increase for the entire year, outperforming the benchmark returns of 2.5% and 12.4% respectively [1] - The depreciation of the U.S. Dollar negatively impacted both the Fund and Benchmark returns when measured in Australian dollars for 2025 [1] - The market environment was characterized as 'risk-on', with defensive sectors like Real Estate and Consumer Staples underperforming, while discretionary consumer businesses had mixed results [1] Group 2: Investment Outlook - The firm anticipates a similar investment environment for 2026 as seen in 2025 and 2024, aiming to avoid extreme events [1] - Ongoing macroeconomic trends and a focus on AI are expected to influence investment strategies, while caution is advised regarding potential adverse outcomes from unexpected areas [1] Group 3: Uber Technologies, Inc. Insights - Uber Technologies, Inc. is highlighted as a key stock in the Fund, with a market capitalization of $143.88 billion, but its stock experienced a one-month return of -8.45% and a 52-week loss of 4.22% [2] - Uber, Jacobs Solutions, and Microsoft each detracted from the Fund's quarterly returns by between 0.5% and 0.8%, but the Fund maintains a long-term positive outlook on these businesses [3] - Uber is considered a 'battleground' company, leading in ridesharing and meal delivery, while also engaging with companies developing autonomous vehicle strategies [4][5]

Core Insights - United Therapeutics (NASDAQ: UTHR) experienced a surge of over 12% in pre-market trading on March 30, driven by positive TETON-1 trial data, leading to price target increases from BofA and Wells Fargo [2][4] - The trial results indicate a significant expansion of Tyvaso's market potential, moving beyond pulmonary arterial hypertension (PAH) to idiopathic pulmonary fibrosis (IPF), which has a considerable unmet medical need [2][6] Price Target Adjustments - BofA raised its price target for United Therapeutics from $569 to $626, maintaining a Neutral rating, citing Tyvaso's potential as both a monotherapy and adjunct therapy for IPF [3][4] - Wells Fargo increased its target from $486 to $575, keeping an Equal Weight rating, and assigned a 95% probability of success for IPF approval, reflecting confidence in the TETON-1 data [3][5] Financial Performance - Tyvaso DPI generated $338.6 million in Q4 2025, marking a 24% year-over-year increase, solidifying its role as the primary growth driver for United Therapeutics [6] - The company's full-year 2025 EPS was reported at $27.86, exceeding estimates, with annual revenue reaching $3,182.7 million [9] Market Reaction - The stock closed at $588.36 on March 30, already above Wells Fargo's revised target and nearing BofA's new target, with a year-to-date gain of 20.75% and a one-year return of 91.67% [8] - The consensus analyst target stands at $605.75, supported by 9 Buy ratings and 4 Hold ratings across the coverage universe [8] Future Catalysts - The next significant catalyst for United Therapeutics is the ADVANCE OUTCOMES readout and targeted FDA submission in H2 2026 for ralinepag in PAH, which could further enhance the company's growth narrative [9]

Core Insights - Infinimmune has entered a partnership with Merck that could be valued at approximately $838 million in milestone payments for the discovery and development of multiple antibodies targeting undisclosed diseases [1][2]. Group 1: Partnership Details - The agreement includes an undisclosed upfront payment to Infinimmune, with potential milestone payments linked to various drug candidates totaling up to $838 million [2]. - Merck will hold exclusive rights to develop and commercialize the antibody candidates resulting from this collaboration [2]. Group 2: Technology and Focus - Infinimmune will utilize its proprietary platform to screen a large number of human immune cells to identify naturally occurring antibodies, employing AI tools for refinement and enhancement [3]. - The specific disease targets selected by Merck for this partnership have not been disclosed [3]. Group 3: Additional Developments - Apart from the collaboration with Merck, Infinimmune is also working on its own early-stage medicines aimed at treating moderate-to-severe eczema and other immune-related diseases [4].

Group 1 - The Company provides publishing services for First Phosphate Corp, receiving annual cash compensation of up to $25,000 for these services [2]

Core Viewpoint - UBS Global Wealth Management maintains a positive outlook on gold prices despite a significant decline since the onset of the Iran war [1] Group 1 - UBS Global Wealth Management's bullish forecasts for gold prices remain unchanged [1] - The firm acknowledges the steep fall in gold prices triggered by geopolitical tensions [1]

Pre-tax profits at the main Irish subsidiary of iPhone maker, Apple last year increased by 6% to $80.96 billion (€70.49 billion) in another record year for the business.New consolidated accounts filed by the Cork based Apple Operations International Ltd (AOIL) show that pre-tax profits increased as revenues rose by $13 billion or 6% from $222.3 billion to $235.3 billion in the 12 months to the end of September 27th last.The pre-tax profits of $80.96 billionn are a $4.6 billion increase on the pre-tax profit ...